COMPARISON OF QUALITY OF LIFE OF PATIENTS WITH LOCAL DISTRIBUTED BREAST CANCER FORMS AFTER CHEMOTHERAPY IN REGIONAL AND SYSTEM REGIMES

Yuriy Dumanskiy, Oleksandr Bondar, Oleksandr Tkachenko, Evhenii Stoliachuk, Vasilii Ermakov

Abstract


For several decades, breast cancer (BC) undoubtedly ranks first in the structure of oncopathology and is the most common cause of the loss of working capacity of the female population in most countries. Considering the increasing quality of care for patients with breast cancer, there is the need for standardization and implementation of methods to assess not only quantitative but also qualitative component of a comprehensive opinion on the results of therapy. Therefore, an important indicator to be taken into account is the quality of life (QL) of a patient.

Definition of QL of patients with inoperable forms of locally advanced breast cancer before and after neoadjuvant courses of systemic polychemotherapy (SPCT) and selective intra-arterial polychemotherapy in combination with systemic (SIAPCT).

154 patients with LA BC T4A-DN0-3M0, who received comprehensive treatment on the basis of the Donetsk regional antitumor center and the University clinic of the Odessa National Medical University during the period from 2000 to 2017, who received SPCT or SIAPCT as a neoadjuvant course, were included in the study.

According to the quality of life during the treatment period, wavelike dynamics with a clear advantage of selective intra-arterial polychemotherapy over the system was observed. According to the quality of health between groups, the marginal statistically significant difference in favour of regional PCTs was formed.

In a detailed study of each of the options found stable symptomatic scale dependent components of the integral index of quality of life on the severity and duration of intoxication syndrome. On the basis of the results obtained, the statistical advantage of the RMRM remains with the regional PCT.

The QL study is a reliable, informative and economical method for assessing the health status of the patient, both at the group and at the individual level. In cancer studies, the evaluation of QL is an important criterion for assessing the effectiveness of treatment and has a prognostic value.


Keywords


locally advanced breast cancer; complex treatment; intra-arterial polychemotherapy; systemic polychemotherapy; quality of life

Full Text:

PDF

References


Aksel, E. M. (2006). Zlokachestvennyie novoobrazovaniya molochnoy zhelezyi: sostoianie onkologicheskoy pomoschi, zabolevaemost i smertnost. Mammologiya, 1, 9–13.

Putyrskiy, L. A., Putyrskogo, Yu. L. (Eds.) (2008). Dobrokachestvennyye i zlokachestvennyye zabolevaniya molochnoy zhelezy. Moscow: Meditsinskoye informatsionnoye agentstvo, 336.

Gantsev, Sh. Kh. (2015). Rak molochnoy zhelezy. Rukovodstvo dlya vrachey. Moscow: GEOTAR-Media, 142.

Shivilov, E. (2011). Rak Molochnoy Zhelezy. Moscow: LAP Lambert Academic Publishing, 200.

Cherenkov, V., Tverezovskiy, S., Petrov, A. (2013). Opukholi molochnoy zhelezy. Moscow: LAP Lambert Academic Publishing, 168.

Khaylenko, V. A., Komov, D. V. (2015). Onkomammologiya. Moscow: MEDpress-inform, 328.

Chen, U. I., Uordli, E. (Eds.) (2009). Rak molochnoy zhelezy. Moscow: Rid Elsiver, 208.

Kit, O. I., Gevorkyan, Yu. A., Soldatkina, N. V. (2011). Organosokhranyayushcheye lechenye raka molochnoy zhelezy. Moscow: LAP Lambert Academic Publishing, 400.

Aleksey, V. (2012). Organosokhranyayushcheye lecheniye bolnykh rakom molochnoy zhelezy. Moscow: LAP Lambert Academic Publishing, 136.

Kuklin, I. (2012). Optimizatsiya khirurgicheskogo lecheniya pri opukholyakh molochnoy zhelezy. Moscow: LAP Lambert Academic Publishing, 208.

Shalimova, S. O. (Eds.) (2012). Rak v Ukrayini, 2010–2011. Zahvoryuvanist, smertnist, pokazniki diyainosti onkologichnoiy sluzhbi. Biuleten natsionalnogo kantser-reestru Ukraiyini. Kyiv, No. 13, 51.

Davydov, M. I., Gantsev, Sh. Kh. (2013). Onkologiya. Moscow: GEOTAR-Media, 920.

Ionova, T. I., Novik, A. A., Suhonos, Yu. A. (1998). Kachestvo zhizni onkologicheskih bolnyih. Voprosi onkologii, 44 (6), 749–752.

Novik, A. A., Ionova, T. I., Kaynd, P. (1999). Kontseptsiya issledovaniya kachestva zhizni v meditsine. Sankt-Peterburg: Elbi, 140.

Tarabrina, N. V., Vorona, O. A., Kurchakova, M. S., Padun, M. A., Shatalova, N. E. (2010). Onkopsikhologiya. Moscow: Institut psikhologii RAN, 176.

Laktionov, K. P., Blokhin, S. N. (2008). Rekonstruktivnyye operatsii pri rake molochnoy zhelezy. Moscow: GEOTAR-Media, 128.

Semiglazov, V. F., Semiglazov, V. V., Kletsel, A. E. (2008). Neoadyuvantnoye i adyuvantnoye lecheniye raka molochnoy zhelezy. Moscow: Meditsinskoye informatsionnoye agentstvo, 288.

Gabka, K. Dzh., Bomert, K. (2010). Plasticheskaya i rekonstruktivnaya khirurgiya molochnoy zhelezy. Moscow: MEDpress-inform, 360.

Semiglazov, V. F., Semiglazov, V. V. (2014). Rak molochnoy zhelezy. Biologiya. mestnoye i sistemnoye lecheniye. Moscow: Spetsialnoye izdatelstvo meditsinskikh knig, 352.

Sedakov, I. E. (2004). Morfologichni kriteriy diagnostiki, otsinka efektivnosti i prognoz pri kombinovanomu likuvanni mistsevo poshirenogo pervinno neoperabelnogo raku molochnoiy zalozi. Ukr. med. almanah, 7 (3), 133–137.

Bondar, А. V., Sedakov, I. E., Shlopov, V. G. (2005). Pervinno neoperabelniy rak molochnoiyi zalozi. Donetsk: Kashtan, 348.




DOI: http://dx.doi.org/10.21303/2504-5679.2018.00635

Refbacks

  • There are currently no refbacks.




Copyright (c) 2018 Yuriy Dumanskiy, Oleksandr Bondar, Oleksandr Tkachenko, Evhenii Stoliachuk, Vasilii Ermakov

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)